Literature DB >> 28229074

Imaging of Cholangiocarcinoma.

Susann-Cathrin Olthof1, Ahmed Othman1, Stephan Clasen1, Christina Schraml1, Konstantin Nikolaou1, Malte Bongers1.   

Abstract

Cholangiocarcinoma (CC) is the second most common primary hepatobiliary tumour, and it is increasing in incidence. Imaging characteristics, behaviour, and therapeutic strategies in CC differ significantly, depending on the morphology and location of the tumour. In cross-sectional imaging, CCs can be classified according to the growth pattern (mass-forming, periductal infiltrating, intraductal) and the location (intrahepatic, perihilar, extrahepatic/distal). The prognosis of CC is unfavourable and surgical resection is the only curative treatment option; thus, early diagnosis (also in recurrent disease) and accurate staging including the evaluation of lymph node involvement and vascular infiltration is crucial. However, the diagnostic evaluation of CC is challenging due to the heterogeneous nature of the tumour. Diagnostic modalities used in the imaging of CC include transabdominal ultrasound, endosonography, computed tomography, magnetic resonance imaging with cholangiopancreatography, and hybrid imaging such as positron emission tomography/computed tomography. In this review, the potential of cross-sectional imaging modalities in primary staging, treatment monitoring, and detection of recurrent disease will be discussed.

Entities:  

Keywords:  Cholangiocarcinoma; Computed tomography; Cross-sectional imaging; Magnetic resonance imaging; Positron emission tomography

Year:  2016        PMID: 28229074      PMCID: PMC5290452          DOI: 10.1159/000453009

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  83 in total

Review 1.  Small for size liver remnant following resection: prevention and management.

Authors:  Rony Eshkenazy; Yael Dreznik; Eylon Lahat; Barak Bar Zakai; Alex Zendel; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.

Authors:  Y Maetani; K Itoh; C Watanabe; T Shibata; F Ametani; H Yamabe; J Konishi
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

Review 3.  [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.

Authors:  Maarten L Donswijk; Søren Hess; Ties Mulders; Marnix G E H Lam
Journal:  PET Clin       Date:  2014-08-12

4.  Optimal MR cholangiopancreatographic sequence and its clinical application.

Authors:  H Irie; H Honda; T Tajima; T Kuroiwa; K Yoshimitsu; K Makisumi; K Masuda
Journal:  Radiology       Date:  1998-02       Impact factor: 11.105

5.  Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI.

Authors:  Y Zhang; M Uchida; T Abe; H Nishimura; N Hayabuchi; Y Nakashima
Journal:  J Comput Assist Tomogr       Date:  1999 Sep-Oct       Impact factor: 1.826

Review 6.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

7.  Comparison of early and delayed FDG PET for evaluation of biliary stricture.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Naruhide Kimura; Akihiro Miki; Yasuhiro Sasakawa; Hisao Wakabayashi; Motoomi Ohkawa
Journal:  Nucl Med Commun       Date:  2007-12       Impact factor: 1.690

8.  Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.

Authors:  Lei Jiang; Hui Tan; Cedric M Panje; Haojun Yu; Yan Xiu; Hongcheng Shi
Journal:  Clin Nucl Med       Date:  2016-01       Impact factor: 7.794

Review 9.  Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.

Authors:  Giovanni Brandi; Michela Venturi; Maria Abbondanza Pantaleo; Giorgio Ercolani
Journal:  Dig Liver Dis       Date:  2015-11-28       Impact factor: 4.088

Review 10.  Cancer review: Cholangiocarcinoma.

Authors:  Yezaz Ahmed Ghouri; Idrees Mian; Boris Blechacz
Journal:  J Carcinog       Date:  2015-02-23
View more
  9 in total

1.  Acute Cholangitis with Atypical Clinical Presentation and Imaging.

Authors:  Chiara Masetti; Arianna Brega; Mario Angelico
Journal:  Dig Dis Sci       Date:  2018-11-03       Impact factor: 3.199

Review 2.  Diagnostic Approach to Suspected Perihilar Malignancy.

Authors:  Evgeny Solonitsyn; Alexander Dechêne
Journal:  Visc Med       Date:  2021-01-19

Review 3.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

Review 4.  Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1.

Authors:  Jean-Marc Dumonceau; Myriam Delhaye; Nicolas Charette; Annarita Farina
Journal:  Therap Adv Gastroenterol       Date:  2020-06-16       Impact factor: 4.409

5.  Incidental biliary dilation in the era of the opiate epidemic: High prevalence of biliary dilation in opiate users evaluated in the Emergency Department.

Authors:  Monique T Barakat; Subhas Banerjee
Journal:  World J Hepatol       Date:  2020-12-27

6.  Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro.

Authors:  Shanshan Fan; Yang Ge; Jian Liu; Heshu Liu; Rui Yan; Tianbo Gao; Xiaona Fan; Zeru Xiao; Guangyu An
Journal:  J Clin Lab Anal       Date:  2021-08-30       Impact factor: 2.352

7.  Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging.

Authors:  Yeun-Yoon Kim; Suk-Keu Yeom; Seung Soo Lee; Mi-Suk Park; Hyejung Shin; Sang Hyun Choi; Hyungjin Rhee; Ji Hoon Park; Eun-Suk Cho; Sumi Park
Journal:  Hepatol Commun       Date:  2021-08-24

8.  Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma.

Authors:  Haoran Wang; Meng He; Zheng Zhang; Wenze Yin; Bixuan Ren; Yujia Lin
Journal:  J Oncol       Date:  2022-09-30       Impact factor: 4.501

9.  Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.

Authors:  Nam Hee Kim; Sung Ryol Lee; Young Hwan Kim; Hong Joo Kim
Journal:  Korean J Radiol       Date:  2020-08-04       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.